泛癌酸-Tn向扩大了CAR治疗到固体瘤的范围
Rafaela Abrantes1, Christopher Forcados2, David J Warren3
1i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
Cell reports. Medicine
|September 9, 2025
概括
研究人员开发了一种新的抗体 (AM52.1),该抗体针对瘤上的酸-Tn (STn) 抗原. 基于AM52.1的CAR T细胞表现出高特异性,并在临床前模型中有效地消除各种癌细胞和瘤.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 准确的瘤特异性标记物对于开发有效的基于仿真抗原受体 (CAR) 的疗法至关重要.
- 异常的碳水化合物结构,如sialyl-Tn (STn) 抗原,由于它们在上皮癌中普遍存在,因此呈现出有希望的瘤特异性标.
- 现有的针对STn的单克隆抗体 (mAbs) 在临床应用中因特异性问题而面临限制.
研究的目的:
- 开发一种高度特异的单克隆抗体 (mAb),向基-Tn (STn) 抗原.
- 为了设计利用AM52.1 mAb用于癌症治疗的CAR T细胞.
- 评估AM52.1CAR T细胞在临床前癌症模型中的疗效和特异性.
主要方法:
- 对STn特异性的AM52.1 mAb的开发和表征.
- 将AM52.1单链可变片段 (scFv) 组装到第二代CAR脚手架中.
- 在体外测试AM52.1CAR T细胞对癌细胞系和患者衍生有机体 (PDO).
- 在胃癌,卵巢管癌和结直肠癌的临床前模型中对AM52.1CAR T细胞的体内评估.
主要成果:
- AM52.1 mAb对STn抗原表现出前所未有的特异性,而对健康组织没有反应性.
- AM52.1CAR T细胞有效地向并消除表达STn的癌细胞系和PDOs.
- AM52.1CAR T细胞在体内对胃,卵巢管瘤和结直肠癌粘膜腹膜转移进行了强有力的控制.
- 经过工程设计的CAR T细胞成功地避免了STn阴性细胞,这表明高点特异性.
结论:
- AM52.1 mAb代表了针对癌症中STn抗原的一种高度特定的工具.
- AM52.1CAR T细胞疗法对表达STn抗原的各种固体瘤具有显著的治疗潜力.
- 这种方法为管理复杂的固体瘤提供了一个有希望的策略,通过利用特定的翻译后修改作为治疗点.
关键词:
在CAR T细胞中,抗体是对抗体的重要组成部分.癌症 癌症 癌症 癌症 癌症葡萄糖生物学 葡萄糖生物学葡萄糖酶化是什么? 葡萄糖酶化是什么?免疫疗法 免疫疗法化-Tnn 的使用.固体瘤是一种固体瘤.更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K